Cti Biopharma Corp buy melinda
Start price
20.01.12
/
50%
€45.75
Target price
20.07.12
€92.50
Performance (%)
-49.62%
End price
20.07.12
€23.05
Summary
This prediction ended on 20.07.12 with a price of €23.05. The BUY prediction by melinda for Cti Biopharma Corp performed very badly with a performance of -49.62%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cti Biopharma Corp | - | - | - | - |
| iShares Core DAX® | -1.087% | 0.196% | 2.094% | 52.050% |
| iShares Nasdaq 100 | -2.463% | -1.792% | 29.248% | 84.785% |
| iShares Nikkei 225® | -5.371% | -5.434% | 54.325% | 69.709% |
| iShares S&P 500 | -0.197% | 1.767% | 23.580% | 69.518% |
Comments by melinda for this prediction
In the thread Cti Biopharma Corp diskutieren
Krebsbehandlung
Cell Therapeutics Inc. sieht vor, dass die Europäische Arzneimittel-Agentur kann eine Stellungnahme über die Zulassung von demnde pixuvry Mitte Februar-Ausgabe
(Laufzeit überschritten)
Stopped prediction by melinda for Cti Biopharma Corp
Cti Biopharma Corp
Start price
Target price
Perf. (%)
€2.00
31.07.18
31.07.18
€2.71
30.10.19
30.10.19
-64.89%
30.10.19
30.10.19
Cti Biopharma Corp
Start price
Target price
Perf. (%)
€10.03
22.05.13
22.05.13
€12.00
22.11.13
22.11.13
52.14%
22.11.13
22.11.13
Cti Biopharma Corp
Start price
Target price
Perf. (%)
€29.17
12.09.12
12.09.12
€40.00
12.03.13
12.03.13
-66.68%
12.03.13
12.03.13